| Post |
| Pre |
| LA |
|---|
| - |
| - |
| ME 1 | ME 2 | ME 3 | ME 4 | ME 5 | ME 6 | ME 7 | ME 8 | ME 9 | ME 10 | Total |
|---|---|---|---|---|---|---|---|---|---|---|
| 2 | 8 | 44 | 610 | 400 | 366 | 194 | 589 | 871 | 5 | 3,089 |
| 1 | 3 | 3 | 330 | 201 | 2 | 25 | 136 | 168 | 2 | 871 |
| Post |
| Pre |
| LO 1 | LO 2 | LO 3 | LO 4 | LO 5A | LO 5B | LO 6 | Total |
|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - |
| - | - | - | - | - | - | - | - |
| AME |
|---|
| - |
| - |
| Post |
| Pre |
| LOP 1 | LOP 2 | LOP 3 | LOP 4 | Total |
|---|---|---|---|---|
| - | - | - | - | - |
| - | - | - | - | - |
| central brain |
|---|
| - |
| - |

| ROI Name | ∑ In | % In | log ratio | ∑ Out | % Out |
|---|---|---|---|---|---|
| ME(L) | 3,089 | 99.8% | -1.83 | 871 | 99.8% |
| Optic-unspecified(L) | 5 | 0.2% | -1.32 | 2 | 0.2% |
| upstream partner | # | NT | conns Mi20 | % In | CV |
|---|---|---|---|---|---|
| Tm3 (L) | 105 | ACh | 351 | 11.7% | 0.8 |
| L5 (L) | 97 | ACh | 227 | 7.6% | 0.8 |
| Dm13 (L) | 7 | GABA | 191 | 6.4% | 1.0 |
| Pm3 (L) | 12 | GABA | 183 | 6.1% | 0.7 |
| Cm2 (L) | 46 | ACh | 177 | 5.9% | 0.8 |
| Mi10 (L) | 40 | ACh | 162 | 5.4% | 0.7 |
| TmY10 (L) | 40 | ACh | 152 | 5.1% | 0.7 |
| Mi4 (L) | 77 | GABA | 144 | 4.8% | 0.6 |
| Tm4 (L) | 49 | ACh | 130 | 4.3% | 0.7 |
| Mi9 (L) | 64 | Glu | 129 | 4.3% | 0.6 |
| Tm1 (L) | 45 | ACh | 105 | 3.5% | 0.6 |
| TmY5a (L) | 62 | Glu | 88 | 2.9% | 0.5 |
| Pm9 (L) | 11 | GABA | 75 | 2.5% | 0.8 |
| MeLo8 (L) | 6 | GABA | 57 | 1.9% | 1.0 |
| Pm2a (L) | 17 | GABA | 56 | 1.9% | 0.8 |
| Tm5a (L) | 22 | ACh | 55 | 1.8% | 0.7 |
| T2a (L) | 34 | ACh | 53 | 1.8% | 0.4 |
| Mi1 (L) | 29 | ACh | 45 | 1.5% | 0.7 |
| TmY9b (L) | 10 | ACh | 38 | 1.3% | 1.0 |
| Dm8a (L) | 20 | Glu | 38 | 1.3% | 0.8 |
| Cm31a (L) | 2 | GABA | 36 | 1.2% | 0.2 |
| ME_unclear (L) | 3 | Glu | 34 | 1.1% | 1.2 |
| Dm2 (L) | 17 | ACh | 27 | 0.9% | 0.5 |
| Cm11d (L) | 4 | ACh | 24 | 0.8% | 0.5 |
| Tm2 (L) | 14 | ACh | 24 | 0.8% | 0.8 |
| Pm2b (L) | 10 | GABA | 21 | 0.7% | 0.6 |
| TmY14 (L) | 15 | unc | 19 | 0.6% | 0.6 |
| MeLo9 (L) | 6 | Glu | 18 | 0.6% | 1.5 |
| Y3 (L) | 8 | ACh | 17 | 0.6% | 0.9 |
| Tm20 (L) | 10 | ACh | 17 | 0.6% | 0.5 |
| Mi18 (L) | 6 | GABA | 14 | 0.5% | 0.6 |
| Pm8 (L) | 7 | GABA | 14 | 0.5% | 0.5 |
| TmY3 (L) | 13 | ACh | 14 | 0.5% | 0.2 |
| TmY21 (L) | 4 | ACh | 13 | 0.4% | 0.5 |
| TmY18 (L) | 9 | ACh | 13 | 0.4% | 0.5 |
| T2 (L) | 9 | ACh | 13 | 0.4% | 0.3 |
| Dm10 (L) | 11 | GABA | 13 | 0.4% | 0.3 |
| TmY15 (L) | 6 | GABA | 11 | 0.4% | 0.5 |
| Cm11b (L) | 6 | ACh | 11 | 0.4% | 0.5 |
| MeLo1 (L) | 6 | ACh | 9 | 0.3% | 0.3 |
| T3 (L) | 3 | ACh | 8 | 0.3% | 0.5 |
| Tm6 (L) | 6 | ACh | 8 | 0.3% | 0.4 |
| Cm10 (L) | 5 | GABA | 7 | 0.2% | 0.3 |
| L2 (L) | 1 | ACh | 6 | 0.2% | 0.0 |
| Cm1 (L) | 4 | ACh | 6 | 0.2% | 0.6 |
| Dm8b (L) | 4 | Glu | 6 | 0.2% | 0.6 |
| MeVPMe1 (R) | 2 | Glu | 6 | 0.2% | 0.0 |
| Dm20 (L) | 5 | Glu | 6 | 0.2% | 0.3 |
| Tm38 (L) | 4 | ACh | 6 | 0.2% | 0.3 |
| LC14b (R) | 5 | ACh | 6 | 0.2% | 0.3 |
| Pm4 (L) | 2 | GABA | 5 | 0.2% | 0.6 |
| Dm9 (L) | 3 | Glu | 5 | 0.2% | 0.6 |
| Tm16 (L) | 3 | ACh | 5 | 0.2% | 0.6 |
| Dm12 (L) | 3 | Glu | 5 | 0.2% | 0.3 |
| Y11 (L) | 3 | Glu | 5 | 0.2% | 0.3 |
| MeVP41 (L) | 1 | ACh | 4 | 0.1% | 0.0 |
| Pm12 (L) | 2 | GABA | 4 | 0.1% | 0.5 |
| MeLo12 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| MeVC25 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| Tm5b (L) | 2 | ACh | 3 | 0.1% | 0.3 |
| TmY19a (L) | 2 | GABA | 3 | 0.1% | 0.3 |
| Mi14 (L) | 3 | Glu | 3 | 0.1% | 0.0 |
| Tm5c (L) | 3 | Glu | 3 | 0.1% | 0.0 |
| Tm5Y (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| MeVP4 (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| MeLo10 (L) | 3 | Glu | 3 | 0.1% | 0.0 |
| MeLo7 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| MeLo14 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Cm19 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| Mi16 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| Tm33 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Tm40 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Cm21 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVC21 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Cm34 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| Y13 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Pm1 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Pm5 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| TmY16 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Pm7 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Cm3 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Tm29 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP3 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| DNc01 (R) | 1 | unc | 1 | 0.0% | 0.0 |
| C3 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Mi2 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| TmY_unclear (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeLo3a (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeLo4 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeLo13 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| TmY17 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Tm39 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Lawf1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| TmY4 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVP1 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Cm17 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Pm6 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Y12 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVPMe3 (R) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVC6 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| Pm13 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| OLVC2 (R) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| OA-AL2i2 (L) | 1 | OA | 1 | 0.0% | 0.0 |
| Dm17 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVC1 (R) | 1 | ACh | 1 | 0.0% | 0.0 |
| downstream partner | # | NT | conns Mi20 | % Out | CV |
|---|---|---|---|---|---|
| TmY3 (L) | 83 | ACh | 530 | 16.8% | 0.7 |
| Tm2 (L) | 133 | ACh | 488 | 15.5% | 0.7 |
| Dm10 (L) | 50 | GABA | 263 | 8.3% | 0.6 |
| Tm1 (L) | 68 | ACh | 171 | 5.4% | 0.6 |
| Mi1 (L) | 83 | ACh | 164 | 5.2% | 0.6 |
| Mi4 (L) | 85 | GABA | 147 | 4.7% | 0.5 |
| Pm2a (L) | 21 | GABA | 143 | 4.5% | 0.7 |
| Dm13 (L) | 6 | GABA | 128 | 4.1% | 0.9 |
| Mi9 (L) | 71 | Glu | 116 | 3.7% | 0.6 |
| Tm4 (L) | 48 | ACh | 76 | 2.4% | 0.4 |
| MeLo8 (L) | 7 | GABA | 72 | 2.3% | 0.9 |
| TmY14 (L) | 30 | unc | 68 | 2.2% | 0.7 |
| Mi14 (L) | 23 | Glu | 63 | 2.0% | 0.6 |
| Dm12 (L) | 25 | Glu | 60 | 1.9% | 0.7 |
| Pm12 (L) | 2 | GABA | 56 | 1.8% | 0.4 |
| T2 (L) | 31 | ACh | 42 | 1.3% | 0.4 |
| Pm4 (L) | 13 | GABA | 41 | 1.3% | 1.0 |
| MeLo7 (L) | 13 | ACh | 38 | 1.2% | 1.0 |
| MeLo3a (L) | 9 | ACh | 33 | 1.0% | 0.4 |
| Tm3 (L) | 20 | ACh | 28 | 0.9% | 0.5 |
| TmY18 (L) | 21 | ACh | 27 | 0.9% | 0.4 |
| Mi18 (L) | 10 | GABA | 26 | 0.8% | 0.6 |
| TmY5a (L) | 20 | Glu | 25 | 0.8% | 0.6 |
| Pm3 (L) | 8 | GABA | 21 | 0.7% | 0.6 |
| Mi10 (L) | 16 | ACh | 19 | 0.6% | 0.3 |
| Tm38 (L) | 10 | ACh | 16 | 0.5% | 0.6 |
| TmY21 (L) | 8 | ACh | 15 | 0.5% | 0.7 |
| MeVP4 (L) | 6 | ACh | 14 | 0.4% | 0.9 |
| Pm2b (L) | 8 | GABA | 14 | 0.4% | 0.6 |
| TmY13 (L) | 11 | ACh | 14 | 0.4% | 0.3 |
| L4 (L) | 9 | ACh | 13 | 0.4% | 0.3 |
| T2a (L) | 12 | ACh | 13 | 0.4% | 0.3 |
| MeLo9 (L) | 8 | Glu | 12 | 0.4% | 0.5 |
| ME_unclear (L) | 2 | Glu | 10 | 0.3% | 0.6 |
| Tm39 (L) | 6 | ACh | 9 | 0.3% | 0.7 |
| MeVP17 (L) | 2 | Glu | 8 | 0.3% | 0.5 |
| Lawf1 (L) | 6 | ACh | 8 | 0.3% | 0.6 |
| Pm9 (L) | 5 | GABA | 8 | 0.3% | 0.5 |
| Tm40 (L) | 6 | ACh | 8 | 0.3% | 0.4 |
| Y3 (L) | 8 | ACh | 8 | 0.3% | 0.0 |
| TmY10 (L) | 5 | ACh | 7 | 0.2% | 0.6 |
| DNc01 (R) | 1 | unc | 6 | 0.2% | 0.0 |
| MeLo1 (L) | 3 | ACh | 6 | 0.2% | 0.4 |
| T3 (L) | 5 | ACh | 6 | 0.2% | 0.3 |
| T1 (L) | 2 | HA | 5 | 0.2% | 0.2 |
| LC14b (R) | 4 | ACh | 5 | 0.2% | 0.3 |
| TmY16 (L) | 4 | Glu | 5 | 0.2% | 0.3 |
| Y14 (L) | 5 | Glu | 5 | 0.2% | 0.0 |
| Dm4 (L) | 1 | Glu | 4 | 0.1% | 0.0 |
| MeVP10 (L) | 2 | ACh | 4 | 0.1% | 0.5 |
| Dm2 (L) | 3 | ACh | 4 | 0.1% | 0.4 |
| Tm16 (L) | 4 | ACh | 4 | 0.1% | 0.0 |
| MeLo3b (L) | 1 | ACh | 3 | 0.1% | 0.0 |
| MeVP23 (L) | 1 | Glu | 3 | 0.1% | 0.0 |
| MeLo12 (L) | 2 | Glu | 3 | 0.1% | 0.3 |
| Tm20 (L) | 3 | ACh | 3 | 0.1% | 0.0 |
| MeVPMe1 (L) | 3 | Glu | 3 | 0.1% | 0.0 |
| L2 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Lawf2 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Pm10 (L) | 1 | GABA | 2 | 0.1% | 0.0 |
| MeVP26 (L) | 1 | Glu | 2 | 0.1% | 0.0 |
| MeVP24 (L) | 1 | ACh | 2 | 0.1% | 0.0 |
| Mi2 (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| Tm6 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| C3 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Pm5 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Tm26 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm12 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Cm2 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm5Y (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm9 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm5b (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| Tm5c (L) | 2 | Glu | 2 | 0.1% | 0.0 |
| TmY17 (L) | 2 | ACh | 2 | 0.1% | 0.0 |
| TmY19a (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| Pm6 (L) | 2 | GABA | 2 | 0.1% | 0.0 |
| MeVPMe2 (R) | 2 | Glu | 2 | 0.1% | 0.0 |
| Tm33 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| L1 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| TmY15 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Tm37 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| L5 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Mi13 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Mi16 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| LOP_ME_unclear (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Pm1 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Tm32 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVP11 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| Pm8 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeLo10 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVPLo1 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| Mi19 (L) | 1 | unc | 1 | 0.0% | 0.0 |
| Cm31a (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| Pm11 (L) | 1 | GABA | 1 | 0.0% | 0.0 |
| MeVPMe12 (L) | 1 | ACh | 1 | 0.0% | 0.0 |
| MeVPMe2 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| MeVC25 (L) | 1 | Glu | 1 | 0.0% | 0.0 |
| 5-HTPMPV03 (R) | 1 | 5-HT | 1 | 0.0% | 0.0 |